Jockovich M, Mendenhall N P, Sombeck M D, Talbert J L, Copeland E M, Bland K I
Department of Radiation Oncology, University of Florida College of Medicine, Gainesville.
Ann Surg. 1994 Jun;219(6):615-21; discussion 621-4. doi: 10.1097/00000658-199406000-00004.
The authors determined the incidence of complications in 133 patients who had undergone staging laparotomy with splenectomy before treatment for Hodgkin's disease (stages I-IV).
Medical records were reviewed, and the patients or their relatives were interviewed. Median follow-up after laparotomy was 15.7 years (range = 2.5-28 years).
Ten episodes of overwhelming postsplenectomy infection (OPSI) were documented in nine patients (6.8%). None of 25 patients who received pneumococcal vaccine before splenectomy developed OPSI. Patients with advanced (stages III-IV) or recurrent Hodgkin's disease were at higher risk of OPSI than those with early disease, and those who received combined modality oncologic therapy were at greater risk than those receiving less intensive treatment. Surgical complications included small bowel obstruction in 13 patients (9.8%), necessitating repeat laparotomy in 9 patients (6.8%), atelectasis in 17 patients, abscess in 3 patients, and 1 wound dehiscence. No deaths occurred as a result of surgical complications. Causes of death in the 29 patients who died included Hodgkin's disease (12 patients), acute treatment-related morbidity (1 patient), leukemia (5 patients), bone marrow failure (3 patients), solid malignancy (2 patients), intercurrent disease (4 patients), unknown causes (1 patient), and OPSI (1 patient).
With presplenectomy pneumococcal vaccination and modern surgical techniques, the long-term risks of laparotomy with splenectomy are acceptable if knowledge of the pathologic extent of abdominal Hodgkin's disease would alter treatment regimens.
作者确定了133例在接受霍奇金病(I - IV期)治疗前行分期剖腹术加脾切除术患者的并发症发生率。
回顾病历,并对患者或其亲属进行访谈。剖腹术后的中位随访时间为15.7年(范围 = 2.5 - 28年)。
9例患者(6.8%)记录到10次暴发性脾切除术后感染(OPSI)。25例在脾切除术前接受肺炎球菌疫苗接种的患者均未发生OPSI。晚期(III - IV期)或复发性霍奇金病患者发生OPSI的风险高于早期疾病患者,接受综合肿瘤治疗的患者比接受强度较低治疗的患者风险更大。手术并发症包括13例小肠梗阻(9.8%),其中9例(6.8%)需要再次剖腹术,17例肺不张,3例脓肿,1例伤口裂开。无手术并发症导致死亡。29例死亡患者的死因包括霍奇金病(12例)、急性治疗相关并发症(1例)、白血病(5例)、骨髓衰竭(3例)、实体恶性肿瘤(2例)、并发疾病(4例)、不明原因(1例)和OPSI(1例)。
通过脾切除术前肺炎球菌疫苗接种和现代手术技术,如果了解腹部霍奇金病的病理范围会改变治疗方案,那么剖腹术加脾切除术的长期风险是可以接受的。